NSU Newsroom
SharkBytes
Horizons
This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.
This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.
NSU Research Spotlight: Evren Alici, M.D., Ph.D.
Evren Alici, M.D., Ph.D.
Evren Alici, M.D., Ph.D., director of the Gene and Cell Therapy Center at Karolinka Institutet in Sweden and a visiting research professor at the NSU Cell Therapy Institute, which will soon be housed in the Center for Collaborative Research. His research is focused on developing treatments for blood and bone marrow cancer patients with multiple myeloma using natural killer (NK) tumor cell interactions for therapeutic potential in cancers and infectious disease. Alici’s research team has developed a method where they heat and shake donated blood with a chemical component, which expands the number of white blood cells and makes them more aggressively attack the tumor. He has published numerous related articles and holds patents in large-scale expansion of primary human NK cells.
Alici received his M.D. degree from Ege University, Faculty of Medicine, Ismir Turkey, and his Ph.D. in Hematology from the Karolinska Institutet in Stockholm, Sweden. He did post-doctoral research as a molecular biologist at Karolinska University Hospital, Huddinge. He is vice president of the Swedish Society of Gene and Cell Therapy, and a member of the European Group for Blood and Marrow Transplantation, the Nordic Blood and Marrow Transplantation Society, the American Society of Hematology, and the European Society of Gene and Cell Therapy.
Alici and fellow researchers at the NSU Cell Therapy Institute were recently profiled in the South Florida Business Journal. Click here to read the article.